Skip to main content

Implementation of an institutional protocol for rational use of blood products and its impact on postoperative cardiac surgery

Introduction

Cardiac surgeries are sometimes followed by significant blood loss and transfusions may be necessary. However, indiscriminate use of blood components can result in detrimental effects for the patient. In this study, we evaluated the short-term effects of the implementation of a protocol for the rational use of blood products in the postoperative period of cardiac surgery.

Methods

Between April and June 2011 an institutional protocol was implemented in a private hospital specialized in cardiology to encourage rational use of blood products with the consent and collaboration of seven cardiac surgery teams. Clinical and demographic data of patients were collected, and the use of blood products and clinical outcomes during in-hospital period 6 months before and after implementation of the protocol were analyzed. The protocol consisted of an institutional campaign with educational intervention in the surgical, intensive care and anesthesiology teams aiming to spread the practice of blood transfusion based on clinical goals (anemia with hemodynamic changes, significant ventricular dysfunction), as well as making routine prescription of epsilon aminocaproic acid (EACA) intraoperatively. Comparisons between categorical variables were performed with the chi-square test and P < 0.05 was considered statistically significant.

Results

After 3 months of implementation of the protocol, the use of EACA rose from 31 to 100%. The surgeries requiring any blood transfusion were 67% before the implementation of the protocol, and 40% in the subsequent months of the same year after implantation (P <0.001). Clinical outcomes related to blood transfusion are presented in Table 1 separating both periods

Table 1 (abstract P58)

Conclusion

The rational use of blood products associated with infusion of ε-aminocaproic acid has the potential to reduce the number of blood transfusions in postoperative of cardiac surgery, which can impact the risk of complications.

Author information

Affiliations

Authors

Corresponding author

Correspondence to PGM de Barros e Silva.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

de Barros e Silva, P., do Amaral Baruzzi, A., Garcia, J. et al. Implementation of an institutional protocol for rational use of blood products and its impact on postoperative cardiac surgery. Crit Care 17, P58 (2013). https://doi.org/10.1186/cc12674

Download citation

Keywords

  • Cardiac Surgery
  • Blood Transfusion
  • Blood Product
  • Educational Intervention
  • Private Hospital